REVELATION BIOSCIENCES INC

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 76135L804 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Armistice Capital, LLC 13G/A Amendment 1	4.99%	209,212	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Armistice Capital, LLC	4.99%	209,212
Steven Boyd	4.99%	209,212
Armistice Capital, LLC 13G	7.8%	323,241	13G	5/15/2026 Event 3/31/2026
Armistice Capital, LLC	7.8%	323,241
Steven Boyd	7.8%	323,241

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q2	12	304 k	$313 k	$0
2026 Q1	11	500 k	$600 k	$0
2025 Q4	1	458	$366.00	$0